These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19218179)

  • 1. Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.
    Zule WA; Costenbader EC; Coomes CM; Wechsberg WM
    Am J Public Health; 2009 Apr; 99 Suppl 1(Suppl 1):S180-6. PubMed ID: 19218179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection.
    Costenbader EC; Zule WA; Coomes CM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):251-8. PubMed ID: 17320314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.
    Latka MH; Hagan H; Kapadia F; Golub ET; Bonner S; Campbell JV; Coady MH; Garfein RS; Pu M; Thomas DL; Thiel TK; Strathdee SA
    Am J Public Health; 2008 May; 98(5):853-61. PubMed ID: 18382005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
    Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
    Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City.
    Howe CJ; Fuller CM; Ompad DC; Galea S; Koblin B; Thomas D; Vlahov D
    Drug Alcohol Depend; 2005 Sep; 79(3):389-95. PubMed ID: 16102381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
    Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.
    Diaz T; Des Jarlais DC; Vlahov D; Perlis TE; Edwards V; Friedman SR; Rockwell R; Hoover D; Williams IT; Monterroso ER
    Am J Public Health; 2001 Jan; 91(1):23-30. PubMed ID: 11189819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
    AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.
    Kwiatkowski CF; Fortuin Corsi K; Booth RE
    Addiction; 2002 Oct; 97(10):1289-94. PubMed ID: 12359033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.
    Zule WA; Oramasionwu C; Evon D; Hino S; Doherty IA; Bobashev GV; Wechsberg WM
    Am J Drug Alcohol Abuse; 2016 Nov; 42(6):689-697. PubMed ID: 27285847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
    Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P
    PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
    Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial to reduce hepatitis C seroincidence in drug users.
    Stein MD; Herman DS; Anderson BJ
    J Addict Dis; 2009 Oct; 28(4):389-98. PubMed ID: 20155608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN).
    Firestone Cruz M; Fischer B; Patra J; Kalousek K; Newton-Taylor B; Rehm J; Tyndall M
    Can J Public Health; 2007; 98(2):130-3. PubMed ID: 17441537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Field CA; Cullen W; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009269. PubMed ID: 23152270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.
    Elliott JC; Hasin DS; Stohl M; Des Jarlais DC
    AIDS Behav; 2016 Mar; 20(3):548-54. PubMed ID: 26080690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities.
    Campbell JV; Hagan H; Latka MH; Garfein RS; Golub ET; Coady MH; Thomas DL; Strathdee SA;
    Drug Alcohol Depend; 2006 Feb; 81(3):259-65. PubMed ID: 16129567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survey of prevalence of HIV infection, syphilis and HCV infection and related risk behaviors among club drug users in Zhejiang, 2011].
    Pan X; Jiang J; He H; Chen L; Yang J; Zhang H; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):934-40. PubMed ID: 26814857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol and HIV sexual risk behaviors among injection drug users.
    Arasteh K; Des Jarlais DC; Perlis TE
    Drug Alcohol Depend; 2008 May; 95(1-2):54-61. PubMed ID: 18242009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.